Cellectis S.A. current report, Q2 FY2019

Cellectis S.A. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K was filed by Cellectis S.A., a foreign private issuer based in Paris, France, on April 2, 2019. The filing serves as a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934. The document primarily acts as a cover sheet for the submission of a press release dated April 2, 2019 (Exhibit 99.1).

Financial Metrics

The provided filing text does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity within this document. The filing text does not provide a clear value for any financial metric.

Material Changes

The filing text does not disclose any material changes versus the prior comparable period. The document serves only to reference an external press release without summarizing its contents.

Guidance, Outlook, and Risks

Management commentary, guidance, outlook, risks, contingencies, and unusual items are not detailed in this filing text. The document references a press release (Exhibit 99.1) which likely contains such information, but the text of that release is not included in the input provided.

Key Facts for Investor Verification

  • The filing is a procedural Form 6-K referencing a press release dated April 2, 2019.
  • No financial statements or operational metrics are included in this specific document text.
  • Investors must review the attached Exhibit 99.1 (Press Release) to obtain details on the company's recent developments or announcements.
  • The registrant files annual reports under Form 20-F.